What is the current market size?

The Enteral Feeding Device Used for Diabetes market size was valued at USD 1.2 billion in 2023, driven by rising diabetes prevalence and demand for home healthcare solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by technological advancements and increased adoption in emerging economies.

What are the primary drivers?

Key drivers include rising chronic diabetes cases, innovations in feeding device technology, and growing patient preference for home-based care solutions.

What challenges hinder market growth?

High product costs, stringent regulatory approvals, and limited awareness in rural areas are major challenges impeding market expansion.

Which regions are leading the market?

North America leads the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region, driven by increasing diabetes prevalence.

Who are the key players?

Leading companies include Medtronic, B. Braun Melsungen AG, Fresenius Kabi, and Nestlé Health Science, focusing on R&D and strategic partnerships.

What future opportunities exist?

Emerging opportunities lie in integrating IoT-enabled devices, expanding into untapped markets, and developing cost-effective solutions for low-income populations.

How does technology impact the market?

Advancements in smart feeding devices with real-time monitoring capabilities are transforming patient care, improving treatment adherence, and reducing hospital readmissions.

What regulations affect the market?

The market is governed by strict FDA and EMA guidelines, emphasizing safety and efficacy, while emerging markets offer growth through evolving regulatory frameworks.

Enteral Feeding Device Used for Diabetes Industry Size, Share & Growth Forecast 2033

Enteral Feeding Device Used for Diabetes by Application (Hospitals, Home Care), by Types (Enteral Feeding Pumps, Enteral Feeding Tubes, Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $85 million

CAGR: 5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Enteral Feeding Device Used for Diabetes Market Overview

Enteral Feeding Devices Used for Diabetes are specialized medical tools designed to deliver nutrients directly to the gastrointestinal tract, bypassing oral intake. These devices are critical for managing diabetes complications where patients experience impaired digestion or nutrient absorption. The global Enteral Feeding Device Used for Diabetes market size is projected to grow significantly, driven by rising diabetes prevalence, technological innovation, and increasing home healthcare adoption. With a growth outlook of 6.2–6.8% CAGR during 2026–2033, the market forecast highlights a shift toward personalized nutrition therapies and advanced monitoring systems. This industry expansion is further supported by regulatory reforms promoting safer devices and reimbursement policy improvements.

Loading chart…

Key forces shaping the market include technological shifts in smart infusion systems with IoT-enabled monitoring and regulatory tailwinds prioritizing device safety standards. North America dominates the market due to high diabetes prevalence and advanced healthcare infrastructure, while the Asia-Pacific region is the fastest-growing market, fueled by rising diabetes incidence and economic expansion. Challenges such as reimbursement constraints in emerging markets and supply chain disruptions may temper growth. Strategic partnerships among manufacturers and healthcare providers will be pivotal to sustain momentum in the Enteral Feeding Device Used for Diabetes market through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	85.00 million
Revenue forecast in 2033	148.24 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius Kabi; Danone; Cardinal Health; Nestle; Avanos Medical; B. Braun; Abbott; Moog; Applied Medical Technology; Cook Medical; Boston Scientific; Vygon; ConMed; BARD; Alcor Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of diabetes globally, particularly type 2 diabetes, is accelerating demand for Enteral Feeding Device Used for Diabetes market solutions, as patients seek precise nutritional management to mitigate complications.

Advancements in smart enteral feeding technologies, such as integration with continuous glucose monitoring systems, are enhancing patient outcomes and driving Enteral Feeding Device Used for Diabetes market size expansion through improved compliance and data-driven care.

Restraints2 items

High costs associated with advanced enteral feeding devices and related healthcare services may limit accessibility in low- and middle-income regions, restraining market penetration.

Stringent regulatory requirements for medical devices, including rigorous clinical trials and approvals, are delaying product launches and increasing development costs for market players.

Opportunities2 items

Growing adoption of home healthcare services is opening avenues for Enteral Feeding Device Used for Diabetes market players to develop user-friendly, portable devices tailored for outpatient settings.

Collaborations between device manufacturers and telemedicine platforms could unlock new revenue streams through remote patient monitoring and personalized nutrition management solutions.

Challenges2 items

Patient resistance to enteral feeding due to perceived invasiveness or lifestyle disruptions poses a significant barrier to market adoption, necessitating robust patient education campaigns.

Intense competition from alternative diabetes management therapies, such as insulin pumps and oral medications, requires Enteral Feeding Device Used for Diabetes market players to differentiate through innovation and clinical evidence.

Market Segmentation

Loading chart…

Enteral Feeding Device Used for Diabetes segmentation by Application reveals two primary categories: Home Care and Inpatient Care. Home Care dominates the market, accounting for ~65% of demand, driven by the rising prevalence of diabetes and patient preference for self-managed therapies in chronic care settings. Devices in this segment prioritize portability, user-friendliness, and compatibility with home-based monitoring systems. Inpatient Care constitutes ~35% of the market, catering to hospitals and clinics where precision delivery, rapid response to complications, and integration with institutional healthcare protocols are critical. This segment is influenced by regulatory standards and hospital procurement policies, with a focus on infection control and device durability. Both applications contribute to market growth, but Home Care is projected to expand faster due to aging populations and telemedicine advancements.

The Types segmentation of the Enteral Feeding Device Used for Diabetes market is divided into Tube-Based Devices and Pump-Assisted Devices. Tube-Based Devices (50% market share) remain the cornerstone for basic nutrient delivery in long-term care scenarios, valued for simplicity, cost-effectiveness, and ease of use. They are predominantly used in geriatric and pediatric populations. Pump-Assisted Devices (50% market share) are gaining traction due to their ability to deliver precise, programmable dosing, which is critical for managing fluctuating blood glucose levels in diabetes patients. This segment benefits from technological innovations, such as smart sensors and connectivity to glucose monitors, enhancing therapeutic outcomes. The competitive landscape is shaped by R&D investments in Pump-Assisted Devices, which are expected to outpace Tube-Based growth as healthcare systems prioritize precision medicine.

Enteral Feeding Device Used for Diabetes Segmentation Breakdown7 items

Application

Hospitals

Home Care

Types

Enteral Feeding Pumps

Enteral Feeding Tubes

Consumables

Regional Insights

Loading chart…

North America dominates the Enteral Feeding Device Used for Diabetes market with a 45% share, driven by advanced healthcare infrastructure and high adoption of specialized diabetes management solutions. Robust regulatory frameworks, such as the FDA’s focus on medical device innovation, and rising investment in R&D by key players further propel growth. The aging population and increasing prevalence of type 2 diabetes underscore demand in this region.

Europe follows with a 30% market share, supported by stringent diabetes care policies and strong reimbursement models. Countries like Germany and the UK prioritize technological advancements, while cross-border collaborations and EU-funded healthcare initiatives enhance ecosystem maturity. However, economic constraints in Southern Europe may limit expansion.

Asia Pacific emerges as the fastest-growing region, with a CAGR of 12% projected through 2030. Rising diabetes prevalence, urbanization, and government efforts to improve healthcare infrastructure (e.g., India’s Ayushman Bharat scheme) are key drivers. Emerging markets like China and Japan are adopting enteral feeding technologies at an accelerated pace due to growing awareness and disposable incomes.

Latin America and the Middle East & Africa collectively account for 15% of the market. In Latin America, partnerships with global manufacturers and expanding healthcare access in Brazil and Mexico are pivotal. The Middle East benefits from high diabetes rates and investment in smart healthcare, though Africa’s growth remains constrained by infrastructure gaps and affordability challenges.

Competitive Landscape

The Enteral Feeding Device Used for Diabetes competitive landscape is moderately consolidated, with a mix of global players and regional specialists vying for market share. Key competitive levers include product innovation, regulatory approvals, and distribution network strength. While global firms dominate in developed markets through established partnerships and diversified portfolios, regional players focus on localized pricing strategies and tailored solutions. The market remains sensitive to compliance costs and supply chain disruptions, which moderate growth for smaller players. Strategic differentiation often centers on technology integration, such as smart feeding systems, and service models catering to hospital and home care settings.

Competitors prioritize M&A to expand market reach, with vertical integration and OEM tie-ups emerging as key strategies to control costs and enhance supply chain resilience. However, margin pressure from reimbursement policies and pricing compression in mature markets pose a significant challenge. Companies also emphasize R&D for non-invasive monitoring features and patient-centric designs to address unmet clinical needs. Regulatory harmonization across regions remains a barrier for firms seeking global scalability, while localized manufacturing hubs are increasingly adopted to mitigate geopolitical risks.

Fresenius Kabi: Innovation pipeline for smart enteral devices

Danone: Premium pricing and hospital channel dominance

Cardinal Health: OEM tie-ups for cost-competitive product offerings

Nestle: R&D focus on pediatric diabetes-specific formulations

Avanos Medical: Regional expansion in emerging markets

B. Braun: Vertical integration to reduce supply chain risks

Key Enteral Feeding Device Used for Diabetes Companies15 items

Fresenius Kabi

Danone

Cardinal Health

Nestle

Avanos Medical

B. Braun

Abbott

Moog

Applied Medical Technology

Cook Medical

Boston Scientific

Vygon

ConMed

BARD

Alcor Scientific

Market Ecosystem

The Enteral Feeding Device Used for Diabetes ecosystem spans upstream technology development, midstream manufacturing and integration, and downstream distribution and clinical application. Value creation occurs through collaboration among suppliers, manufacturers, and healthcare stakeholders to address patient needs, regulatory requirements, and clinical integration. The ecosystem is shaped by innovation in enteral nutrition systems, precision diabetes management technologies, and the operational demands of healthcare delivery.

Raw material/component suppliers — provide medical-grade polymers, sensors, and tubing for device construction

OEMs/Manufacturers — design and produce enteral feeding devices with diabetes-specific features

Technology providers — develop precision dosing algorithms and connectivity solutions for glucose monitoring

System integrators — assemble and validate device components for clinical safety and performance

Distributors/Channel partners — manage logistics and market access to healthcare facilities and pharmacies

Service providers/After-sales — offer calibration, maintenance, and training for device users

Regulators/Standards bodies — enforce compliance with medical device safety and performance regulations

Control points in the ecosystem reside with regulators, who dictate compliance pathways, and key manufacturers, who manage intellectual property and component standardization. Dependency risks include raw material availability and adherence to evolving diabetes care guidelines. Switching costs for healthcare providers are influenced by device interoperability with existing monitoring systems and clinician familiarity. Strategic partnerships between manufacturers and clinical institutions ensure tailored solutions, while regional variations in regulatory frameworks and reimbursement policies create localized adoption barriers.

Recent Industry Insights

The Enteral Feeding Device Used for Diabetes industry trends have seen notable advancements over the past 18 months, driven by innovation and shifting healthcare priorities. Strategic partnerships have emerged, such as collaborations between enteral device manufacturers and diabetes care platforms to integrate real-time glucose monitoring with feeding schedules, enhancing personalized care. In M&A activity, major healthcare conglomerates have acquired niche enteral device firms to strengthen their foothold in specialized nutrition technologies. Product launches have focused on smart devices with IoT-enabled features, allowing remote patient monitoring and automated dosage adjustments, addressing rising demand for home-based care solutions. Regulatory bodies, including the FDA, have updated guidelines to streamline approvals for enteral devices incorporating AI-driven analytics, fostering faster market entry. Meanwhile, a shift in consumer trends toward preventive diabetes management has spurred R&D into portable, user-friendly devices. Funding rounds have accelerated, with startups securing Series A investments to scale production of devices tailored for pediatric diabetes patients, signaling long-term growth in this underserved segment.

Analyst Overview

The Enteral Feeding Device Used for Diabetes market outlook remains attractive, driven by rising diabetes prevalence, an aging population, and growing demand for precision nutrition management. Competitive intensity is moderate, with established players dominating but niche innovators emerging through specialized product designs and digital integration. The long-term outlook is optimistic, supported by advancements in smart enteral systems and expanding applications in chronic disease management. The innovation landscape is dynamic, focusing on smart devices with real-time glucose monitoring and AI-driven nutrient delivery to address patient-specific needs. Demand–supply balance is generally stable in developed regions but strained in emerging markets due to infrastructure gaps and cost barriers. Key risk factors include regulatory scrutiny, reimbursement challenges, and product safety concerns. Strategic collaborations and R&D investment will be critical for sustaining growth in this evolving sector.

11 items

1. Executive Summary

2. Enteral Feeding Device Used for Diabetes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Enteral Feeding Device Used for Diabetes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Enteral Feeding Device Used for Diabetes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Home Care

6.2. Global Enteral Feeding Device Used for Diabetes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Enteral Feeding Pumps

6.2.2. Enteral Feeding Tubes

6.2.3. Consumables

6.3. Global Enteral Feeding Device Used for Diabetes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Enteral Feeding Device Used for Diabetes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Enteral Feeding Device Used for Diabetes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Enteral Feeding Device Used for Diabetes Market Competition by Key Manufacturers

8.1. Global Enteral Feeding Device Used for Diabetes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Enteral Feeding Device Used for Diabetes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Fresenius Kabi

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Danone

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardinal Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Nestle

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Avanos Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. B. Braun

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Abbott

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Moog

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Applied Medical Technology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cook Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Boston Scientific

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Vygon

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. ConMed

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. BARD

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Alcor Scientific

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Enteral Feeding Device Used for Diabetes Market

Figure 4: Global Enteral Feeding Device Used for Diabetes Market: Drivers

Figure 5: Global Enteral Feeding Device Used for Diabetes Market: Challenges

Figure 6: Global Enteral Feeding Device Used for Diabetes Market: Trends

Figure 7: Global Enteral Feeding Device Used for Diabetes Market: Opportunity

Figure 8: Global Enteral Feeding Device Used for Diabetes Market: Restraint

Figure 9: Global Enteral Feeding Device Used for Diabetes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Enteral Feeding Device Used for Diabetes Market Value (USD Million) By Region

Figure 15: Global Enteral Feeding Device Used for Diabetes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Enteral Feeding Device Used for Diabetes Market Value (USD Million) By Region

Figure 23: Global Enteral Feeding Device Used for Diabetes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Enteral Feeding Device Used for Diabetes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Enteral Feeding Device Used for Diabetes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Enteral Feeding Device Used for Diabetes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Enteral Feeding Device Used for Diabetes Market Value (USD Million) By Region

Table 10: Global Enteral Feeding Device Used for Diabetes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Enteral Feeding Device Used for Diabetes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Enteral Feeding Device Used for Diabetes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Enteral Feeding Device Used for Diabetes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Fresenius Kabi Basic Information And Sales Area

Table 31: Fresenius Kabi. Products Portfolio

Table 32: Danone Basic Information And Sales Area

Table 33: Danone. Products Portfolio

Table 34: Cardinal Health Basic Information And Sales Area

Table 35: Cardinal Health. Products Portfolio

Table 36: Nestle Basic Information And Sales Area

Table 37: Nestle. Products Portfolio

Table 38: Avanos Medical Basic Information And Sales Area

Table 39: Avanos Medical. Products Portfolio

Table 40: B. Braun Basic Information And Sales Area

Table 41: B. Braun. Products Portfolio

Table 42: Abbott Basic Information And Sales Area

Table 43: Abbott. Products Portfolio

Table 44: Moog Basic Information And Sales Area

Table 45: Moog. Products Portfolio

Table 46: Applied Medical Technology Basic Information And Sales Area

Table 47: Applied Medical Technology. Products Portfolio

Table 48: Cook Medical Basic Information And Sales Area

Table 49: Cook Medical. Products Portfolio

Table 50: Boston Scientific Basic Information And Sales Area

Table 51: Boston Scientific. Products Portfolio

Table 52: Vygon Basic Information And Sales Area

Table 53: Vygon. Products Portfolio

Table 54: ConMed Basic Information And Sales Area

Table 55: ConMed. Products Portfolio

Table 56: BARD Basic Information And Sales Area

Table 57: BARD. Products Portfolio

Table 58: Alcor Scientific Basic Information And Sales Area

Table 59: Alcor Scientific. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Enteral Feeding Device Used for Diabetes Market Value (USD Million) By Region

Table 65: Global Enteral Feeding Device Used for Diabetes Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Enteral Feeding Device Used for Diabetes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	85.00 million
Revenue forecast in 2033	148.24 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius Kabi; Danone; Cardinal Health; Nestle; Avanos Medical; B. Braun; Abbott; Moog; Applied Medical Technology; Cook Medical; Boston Scientific; Vygon; ConMed; BARD; Alcor Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs associated with advanced enteral feeding devices and related healthcare services may limit accessibility in low- and middle-income regions, restraining market penetration.

Stringent regulatory requirements for medical devices, including rigorous clinical trials and approvals, are delaying product launches and increasing development costs for market players.

Opportunities2 items

Collaborations between device manufacturers and telemedicine platforms could unlock new revenue streams through remote patient monitoring and personalized nutrition management solutions.

Challenges2 items

Patient resistance to enteral feeding due to perceived invasiveness or lifestyle disruptions poses a significant barrier to market adoption, necessitating robust patient education campaigns.

Market Segmentation

Loading chart…

Enteral Feeding Device Used for Diabetes Segmentation Breakdown7 items

Application

Hospitals

Home Care

Types

Enteral Feeding Pumps

Enteral Feeding Tubes

Consumables

Regional Insights

Loading chart…

Competitive Landscape

Fresenius Kabi: Innovation pipeline for smart enteral devices

Danone: Premium pricing and hospital channel dominance

Cardinal Health: OEM tie-ups for cost-competitive product offerings

Nestle: R&D focus on pediatric diabetes-specific formulations

Avanos Medical: Regional expansion in emerging markets

B. Braun: Vertical integration to reduce supply chain risks

Key Enteral Feeding Device Used for Diabetes Companies15 items

Fresenius Kabi

Danone

Cardinal Health

Nestle

Avanos Medical

B. Braun

Abbott

Moog

Applied Medical Technology

Cook Medical

Boston Scientific

Vygon

ConMed

BARD

Alcor Scientific

Market Ecosystem

Raw material/component suppliers — provide medical-grade polymers, sensors, and tubing for device construction

OEMs/Manufacturers — design and produce enteral feeding devices with diabetes-specific features

Technology providers — develop precision dosing algorithms and connectivity solutions for glucose monitoring

System integrators — assemble and validate device components for clinical safety and performance

Distributors/Channel partners — manage logistics and market access to healthcare facilities and pharmacies

Service providers/After-sales — offer calibration, maintenance, and training for device users

Regulators/Standards bodies — enforce compliance with medical device safety and performance regulations

Recent Industry Insights

Analyst Overview

Table of Contents